Home Stakeholders Health & Social Care Stakeholders Medical and Pharmaceutical Research Unit

Medical and Pharmaceutical Research Unit

The Medical and Pharmaceutical Statistics (MPS) Research Unit develops and evaluates novel statistical methods of study design and data analysis for use in the pharmaceutical and medical research community.

The Medical and Pharmaceutical Statistics Research Unit work with partners in heath care, the public sector and pharmaceutical industry. We offer a number of services:

Many of our services are supported by our partners:

MRC North West Hub for Trial Methodology Research       Click here to visit the Lancaster University website


The Unit exists to develop and evaluate novel statistical methods of study design and data analysis relevant to pharmaceutical companies and medical research institutes. We undertake methodological research, often in direct collaboration with companies, and provide professional development courses and a consultancy service.

Our main areas of research and expertise are:

Professional Development Courses

The MPS Research Unit has prepared a suite of professional development courses that may be commissioned by a company or organisation, tailored to meet special requirements and presented at a location of your choice both for statisticians and non-statisticians. A selection of these courses is scheduled each year for presentation at Lancaster University.

For more information, click here.


We work with partners in public sector medical research institutions and the pharmaceutical industry. Our services are available for anyone interested in statistical methods for drug development and are frequently taken up by pharmaceutical companies, medical research institutions and clinical trial units.

Collaborations with our partners range from providing advice and consultancy for clinical and pre-clinical studies over the course of a few days to the joint development and publication of novel methodology in research partnerships that last several years. Experience with regulators has included attendance at meetings to discuss design issues, participation in teleconferences and correspondence about protocols and attendance at final licensing hearings. Most of these contacts have concerned the FDA, but others have been with European agencies. Our professional development courses are aimed at graduate level statisticians with experience in the industry, and are scheduled in Lancaster as well as being available for presentation at a client’s own site.